Empirica Therapeutics

Empirica Therapeutics is a developer of therapeutic drugs for the treatment of aggressive cancers. The company is dedicated to developing adoptive immunotherapies targeting the most aggressive and drug-resistant cancers, including glioblastoma (GBM) and brain metastases (BM), creating better treatment opportunities for cancers with significant unmet needs.